Why Respiri

• 250k people die from asthma each year, with most of these avoidable. Currently there is no reliable, easy to use self-monitoring product that can objectively measure the key symptom in wheeze. Most asthma foundations and health bodies acknowledge that the analogue peak-flow meter is outdated and limited in its usefulness. It is time that asthma caught up to the other major chronic diseases (diabetes, cardiac) in having a useful digital objective symptom self-monitoring solution.

We are only month away, when Respiri’s wheeze monitor and overnight monitor are released to the market.
They will objectively monitor the key symptoms of asthma and will assist GP’s correct prescriptions.

There are still shares available under 10 cents, get them NOW before sanity sets in!!!